Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 9926 [2013-03134]
Download as PDF
<![CDATA[
9926
Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices
tuberculosis-related issues. Agenda
items are subject to change as priorities
dictate.
Contact Person for More Information:
Margie Scott-Cseh, CDC, 1600 Clifton
Road, NE., M/S E–07, Atlanta, Georgia
30333, telephone (404) 639–8317;
Email: zkr7@cdc.gov
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2013–03133 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
tkelley on DSK3SPTVN1PROD with NOTICES
The meeting announced below
concerns Medicaid Expansion and
Reproductive Health Care for Women,
FOA DP 13–002, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–5:00 p.m., April
4, 2013 (Closed).
Place: Teleconference .
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Medicaid Expansion and
Reproductive Health Care for Women, FOA
DP 13–002, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
VerDate Mar<15>2010
16:40 Feb 11, 2013
Jkt 229001
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2013–03131 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Prevalence and Incidence of
Inflammatory Bowel Disease, FOA DP
13–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date:
11:00 a.m.–5:00 p.m., April 16, 2013
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Prevalence and Incidence of
Inflammatory Bowel Disease, FOA DP 13–
001, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–03132 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Cooperative Research
Agreements Related to the World Trade
Center Health Program (U01) PAR 12–
126, initial review.
Correction: The notice was published
in the Federal Register on January 30,
2013, Volume 78, Number 20, Page
6329. The place should read as follows:
Place: Atlanta Marriott Century
Center, 2000 Century Boulevard NE.,
Atlanta, Georgia 30345–3306,
Telephone: (404) 325–0000.
Contact Person for More Information:
Nina Turner, Ph.D., Scientific Review
Officer, CDC, 1095 Willowdale Road,
Mailstop G800, Morgantown, West
Virginia 26505, Telephone: (304) 285–
5976.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–03134 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Cost-Benefit of Incentive-based
Smoking Cessation for Pregnant
Women, FOA DP 13–003, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–5:00 p.m., April
2, 2013 (Closed).
Place: Teleconference .
Status: The meeting will be closed to the
public in accordance with provisions set
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 78, Number 29 (Tuesday, February 12, 2013)]
[Notices]
[Page 9926]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03134]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Cooperative Research
Agreements Related to the World Trade Center Health Program (U01) PAR
12-126, initial review.
Correction: The notice was published in the Federal Register on
January 30, 2013, Volume 78, Number 20, Page 6329. The place should
read as follows:
Place: Atlanta Marriott Century Center, 2000 Century Boulevard NE.,
Atlanta, Georgia 30345-3306, Telephone: (404) 325-0000.
Contact Person for More Information: Nina Turner, Ph.D., Scientific
Review Officer, CDC, 1095 Willowdale Road, Mailstop G800, Morgantown,
West Virginia 26505, Telephone: (304) 285-5976.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-03134 Filed 2-11-13; 8:45 am]
BILLING CODE 4163-18-P
